Rivacor 7 Dr-T
Payments companies reported to CMS as associated with Rivacor 7 Dr-T. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Rivacor 7 Dr-T, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Rivacor 7 Dr-T
These are the largest totals companies reported as associated with Rivacor 7 Dr-T. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gaurav Upadhyay | Chicago, IL | Clinical Cardiac Electrophysiology | $125,130.87 |
| Chad Bonhomme | Westfield, IN | Clinical Cardiac Electrophysiology | $58,090.00 |
| Marrick Kukin | New York, NY | Cardiovascular Disease | $15,115.00 |
| James Heywood | La Jolla, CA | Advanced Heart Failure and Transplant Cardiology | $12,400.00 |
| Emil Missov | Greenville, NC | Advanced Heart Failure and Transplant Cardiology | $7,200.00 |
| Emad Aziz | Newark, NJ | Clinical Cardiac Electrophysiology | $6,600.00 |
| Roderick Tung | Chicago, IL | Clinical Cardiac Electrophysiology | $2,727.74 |
| Antonio Moretta | Sarasota, FL | Clinical Cardiac Electrophysiology | $2,142.78 |
| Kalyanam Shivkumar | Los Angeles, CA | Cardiovascular Disease | $1,909.72 |
| Gregory Harris | Greenville, NC | Clinical Cardiac Electrophysiology | $1,685.68 |
Prescribed Rivacor 7 Dr-T?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.